Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ORGO
ORGO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ORGO News
Organogenesis Completes PuraPly AM Clinical Trial for Diabetic Foot Ulcers
Apr 07 2026
NASDAQ.COM
Organogenesis Shares Surge 29% After Successful Clinical Trial for PuraPlyAM
Apr 07 2026
seekingalpha
Organogenesis Completes PuraPly®AM Clinical Trial with Significant Results
Apr 06 2026
Newsfilter
Organogenesis Shares Surge After FDA Meeting on ReNu Approval
Apr 06 2026
stocktwits
Organogenesis Completes FDA Meeting, Plans BLA Submission
Apr 06 2026
Newsfilter
Organogenesis Holdings Inc. to Begin Rolling BLA for Renu After Positive FDA Meeting
Apr 06 2026
moomoo
Organogenesis to Report Q1 2026 Financial Results on May 7
Apr 06 2026
Newsfilter
Organogenesis Reports Record Q4 2025 Earnings Amid Market Uncertainty
Feb 27 2026
seekingalpha
Pomerantz LLP Investigates Securities Fraud Claims Against Organogenesis Holdings
Feb 03 2026
Globenewswire
Pomerantz LLP Investigates Securities Fraud Claims Against Organogenesis Holdings Inc.
Jan 22 2026
PRnewswire
Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%
Jan 08 2026
PRnewswire
Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%
Jan 06 2026
Globenewswire
Avista Healthcare Partners Promotes Three Key Executives in Investment Team
Jan 05 2026
Newsfilter
Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%
Dec 30 2025
Globenewswire
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split, Shares Plunge 38.4%
Dec 26 2025
Benzinga
Organogenesis Submits BLA for ReNu, Expected Completion in 2026
Dec 24 2025
NASDAQ.COM
Show More News
